Nutex Health (NUTX) - 2021 Q2 - Quarterly Report

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly period ended June 30, 2021. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number 000-53862 Clinigence Holdings, Inc. (Exact name of small business issuer as specified in its charter) Delaware 11-3363609 (State or other jurisdiction of incorporatio ...